Our study demonstrates that monocytes, a myeloid cell subset, are recruited into inflamed tumor tissues and proliferate after anti-PD-1/CTLA-4 treatment, where they can mediate suppressor roles or rapidly differentiate to dendritic cells upon Ly6C blockade. This evidence concerns the gene CTLA4 and neoplasm.